Search

everythinglearnresearchcommunity

for

Search:↓

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

Severe hair loss links to metabolic issues in older men with psoriasis.

Ixekizumab helps improve life quality, physical ability, and work performance in patients with psoriatic arthritis who haven't used biologic drugs before.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Obesity is linked to various skin problems and may increase the risk of skin cancer.

Environmental factors, hormones, nutrition, and stress all significantly affect skin health and aging.

Antioxidants may help fight oxidative stress linked to autoimmune skin diseases.

Advanced human skin models improve drug development and could replace animal testing.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

Human skin produces sex hormones like estrogen and testosterone, influenced by ARO and StAR, which may affect skin elasticity and hair growth.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

Changes in keratin affect skin health and can lead to skin disorders like blistering diseases and psoriasis.

Traditional and complementary medicine may help with skin conditions, but more high-quality research is needed.

Retinoids can prevent skin cancer in high-risk people but have side effects and require more research on dosing and effectiveness.

Psychotropic medications can cause skin problems but also treat some skin conditions.

HIV can cause skin disorders, which are often the first sign of infection, especially in people with darker skin.

Sam Shuster identified three types of hair loss in psoriasis and emphasized the need for better research to understand them.

Some skin diseases may indicate a higher risk of metabolic syndrome and related health issues.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

The document concludes that autoimmune skin disorders are treated with corticosteroids and immunosuppressive drugs.

Early regulatory T cells are crucial for normal skin pigmentation.

TNC+ fibroblasts play a key role in skin inflammation by interacting with T cells.

More research with diverse participants is needed to determine the effectiveness of photobiomodulation devices for hair loss treatment.

HPH-15, a new compound, effectively reduces skin fibrosis in experiments without causing harm.

Obesity affects skin health, causing conditions like acanthosis nigricans and may require different treatment approaches.

Stem cells are crucial for skin repair and new treatments for chronic wounds.

Bone Morphogenetic Proteins (BMPs) help control skin health, hair growth, and color, and could potentially be used to treat skin and hair disorders.

Nanoparticles improve drug delivery through the skin but more research is needed on their long-term effects and skin penetration challenges.

Nanoparticles can improve skin drug delivery but have challenges like toxicity and stability that need more research.